Trial watch: Dendritic cell-based anticancer immunotherapy

by Abhishek D. Garg, Monica Vara Perez, Marco Schaaf, Patrizia Agostinis, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi
Published 2017-07-01

Anticancer effects of anti-CD47 immunotherapy in vivo

by Kristina Iribarren, Aitziber Buque, Laura Mondragon, Wei Xie, Sarah Lévesque, Jonathan Pol, Laurence Zitvogel, Oliver Kepp, Guido Kroemer
Published 2019-03-01

Trial watch: dendritic cell vaccination for cancer immunotherapy

by Jenny Sprooten, Jolien Ceusters, An Coosemans, Patrizia Agostinis, Steven De Vleeschouwer, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi, Abhishek D. Garg
Published 2019-11-01

Trial Watch: Adoptively transferred cells for anticancer immunotherapy

by Carole Fournier, François Martin, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi, Lionel Apetoh
Published 2017-11-01

Trial Watch: Toll-like receptor agonists in cancer immunotherapy

by Melody Smith, Elena García-Martínez, Michael R. Pitter, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi
Published 2018-12-01

Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors

by Jonathan G. Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Boeuf, Derek R. Clements, Jean-Eudes Fahrner, Laetitia Fend, John C. Bell, Karen L. Mossman, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi
Published 2018-12-01

Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies

by Shashi Gujar, Jonathan G. Pol, Guido Kroemer
Published 2018-08-01

Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy

by Romain Daillère, Lisa Derosa, Mélodie Bonvalet, Nicola Segata, Bertrand Routy, Manuela Gariboldi, Eva Budinská, I. Jolanda M. De Vries, Alessio Gordon Naccarati, Valérie Zitvogel, Carlos Caldas, Lars Engstrand, Sibylle Loilbl, Jacques Fieschi, Lucie Heinzerling, Guido Kroemer, Laurence Zitvogel
Published 2020-01-01

Metabolic Reprogramming by Reduced Calorie Intake or Pharmacological Caloric Restriction Mimetics for Improved Cancer Immunotherapy

by Erwan Eriau, Juliette Paillet, Guido Kroemer, Jonathan G. Pol
Published 2021-03-01

Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts

by Gautier Stoll, Jonathan Pol, Vassili Soumelis, Laurence Zitvogel, Guido Kroemer
Published 2018-10-01

Repurposing CD8+ T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?

by Shashi Gujar, Jonathan G. Pol, Youra Kim, Guido Kroemer
Published 2020-01-01

Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy

by Francesca Castoldi, Erika Vacchelli, Laurence Zitvogel, Maria Chiara Maiuri, Federico Pietrocola, Guido Kroemer
Published 2019-01-01

Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancer

by Oliver Kepp, Laurence Zitvogel, Guido Kroemer
Published 2020-01-01

Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses

by Peng Liu, Liwei Zhao, Gladys Ferrere, Carolina Alves-Costa-Silva, Pierre Ly, Qi Wu, Ai-Ling Tian, Lisa Derosa, Laurence Zitvogel, Oliver Kepp, Guido Kroemer
Published 2020-01-01

Crizotinib – a tyrosine kinase inhibitor that stimulates immunogenic cell death

by Peng Liu, Liwei Zhao, Oliver Kepp, Guido Kroemer
Published 2019-07-01

Contribution of annexin A1 to anticancer immunosurveillance

by Elisa Elena Baracco, Gautier Stoll, Peter Van Endert, Laurence Zitvogel, Erika Vacchelli, Guido Kroemer
Published 2019-11-01

Potent immunosuppressive effects of the oncometabolite R-2-hydroxyglutarate

by Lorenzo Galluzzi, Guido Kroemer
Published 2018-12-01

Endogenous and exogenous glucocorticoids abolish the efficacy of immune-dependent cancer therapies

by Yuting Ma, Heng Yang, Guido Kroemer
Published 2020-01-01

Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients

by Lenka Kasikova, Michal Hensler, Iva Truxova, Petr Skapa, Jan Laco, Lucie Belicova, Ivan Praznovec, Sarka Vosahlikova, Michael J. Halaska, Tomas Brtnicky, Lukas Rob, Jiri Presl, Jan Kostun, Isabelle Cremer, Ales Ryska, Guido Kroemer, Lorenzo Galluzzi, Radek Spisek, Jitka Fucikova
Published 2019-11-01

Trial Watch: experimental TLR7/TLR8 agonists for oncological indications

by Giorgio Frega, Qi Wu, Julie Le Naour, Erika Vacchelli, Lorenzo Galluzzi, Guido Kroemer, Oliver Kepp
Published 2020-01-01